tradingkey.logo

NeuroOne Medical Technologies Corp

NMTC
View Detailed Chart
0.780USD
+0.045+6.16%
Close 02/06, 16:00ETQuotes delayed by 15 min
39.02MMarket Cap
LossP/E TTM

NeuroOne Medical Technologies Corp

0.780
+0.045+6.16%
Intraday
1m
30m
1h
D
W
M
D

Today

+6.16%

5 Days

-11.83%

1 Month

-20.42%

6 Months

-2.46%

Year to Date

+2.94%

1 Year

-21.40%

View Detailed Chart

Key Insights

NeuroOne Medical Technologies Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 79 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 2.30.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

NeuroOne Medical Technologies Corp's Score

Industry at a Glance

Industry Ranking
79 / 205
Overall Ranking
214 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

NeuroOne Medical Technologies Corp Highlights

StrengthsRisks
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 250.82% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 12.10M.
Undervalued
The company’s latest PE is -8.69, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 16.80M shares, decreasing 3.74% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 692.60K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.35.

Analyst Rating

Based on 2 analysts
Strong Buy
Current Rating
2.300
Target Price
+212.93%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

NeuroOne Medical Technologies Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

NeuroOne Medical Technologies Corp Info

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Ticker SymbolNMTC
CompanyNeuroOne Medical Technologies Corp
CEORosa (David A)
Websitehttps://nmtc1.com/
KeyAI